Daniel Stadlbauer

Rising to the challenge of COVID-19 A series of Features highlights how scientists transform their labs and refocus research efforts Read the 1st interview with @florian_krammer @DanielStadlb @FatimaAmanat at the Icahn School of Medicine at Mount Sinai rdcu.be/b5TGe

Join our next ASciNA Virtual Talk Development & Application of a #COVID19 Antibody Test - Dr. Daniel Stadlbauer @DanielStadlb at @florian_krammer Lab @IcahnMountSinai Time: 12:00pm EST, July 16 Join here: shorturl.at/xEGY5 Please RVSP by July 15 to events@ascina.at

Development of an enzyme-linked immunosorbent assay to detect antibodies to the #SARSCoV2 spike protein in human sera and plasma. @florian_krammer @FatimaAmanat @DanielStadlb @VivianaSimonLab @kedzierskalab @Shirin_Strohm #seroconversion #COVID19 #ELISA go.nature.com/3csMPS7

OK, our detailed protocol for SARS-CoV-2 antigen expression and two-step ELISA set up is now officially out at Current Protocols in Microbiology (open access of course): …rentprotocols.onlinelibrary.wiley.com/doi/10.1002/cp… with @DanielStadlb @FatimaAmanat and the rest of the crew!

Aubree and I are explaining serological testing for SARS-CoV-2 and why testing (a lot) is helpful. @AubreeGordonPhD

I think it is official now. FDA gave our two-step ELISA an emergency use authorization! Great collaboration between Mount Sinai's clinical lab (Drs. Carlos Cordon-Cardo, Adolfo Firpo, Rao Damodara Mendu and Jeffrey Jhang) and my team! fda.gov/media/137032/d…

Most New York coronavirus cases were seeded by people who had traveled in Europe, not Asia, an analysis of genomes shows.  nyti.ms/2RuKaPk

.@CDCgov has started doing serology studies aimed at finding how far and fast #Covid19 is spreading. statnews.com/2020/04/04/cdc…

.@MountSinaiNYC to begin the transfer of #COVID19 antibodies into critically ill patients: bit.ly/2WKAy6C